The Drug and Chemical Evaluation Section (DOE)

The Drug and Chemical Evaluation Section of the Department of Justice Drug Enforcement Administration published a Special Notice requesting the purchase of synthetic substances from Cayman Chemical. The Special Notice involves procuring substances for pharmacological testing purposes to enrich information about drugs of concern and potentially schedule substances not currently controlled.

The Special Notice details a single source procurement from Cayman Chemical, as they were the only vendor able to provide all substances listed by the deadline of January 2024 through January 2025. Any delay in procurement or testing could prolong health hazards to the public. The contracting officer certified this as a single-source acquisition with fair and reasonable pricing required. The purpose is to obtain synthetic substances for diversion and control purposes to be used in pharmacological testing by the Drug and Chemical Evaluation Section. The opportunity is not set aside and proposals were due by January 24, 2024 from Cayman Chemical.